Abstract
TI-201 is one of the most common tumor-seeking agents in clinical use, but it has been used principally for imaging lung, thyroid, and head and neck cancer. TI-201 is taken up by viable tumor rather than by necrotic or scar tissue. In the current report, an 80-year-old woman with a protruding and ulcerative mass on her left vulva was hospitalized for dual-phase TI-201 cancer survey with abnormal tracer uptake seen in the vulvar region and pelvic lymph nodes. Histopathologic findings were squamous cell carcinomas of the vulva with pelvic lymph node metastases.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
